Allogene Therapeutics Reports Third Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports Third Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 2.03 -0.05 (2.4%)
Previous Close $2.08    52 Week High
Open $2.07    52 Week Low
Day High $2.09    P/E N/A 
Day Low $2.00    EPS
Volume 4,088,207